iPierian Case Solution
The iPierian case profiles a start-up biotechnology business leveraging the current advancement of caused pluripotent stem cells (iPSCs)-- adult stem cells that have actually been reprogrammed to a "pluripotent" state whereby they can separate into around 200 various cell key ins the body. The science here in this field remains in the nascent phases however the speed of modification is fast as brand-new discoveries are made and as business develop treatments for the innovation. iPierian has actually developed itself as an early leader in the area by producing a constant method to develop elevated volumes of superior quality iPSCs and consequently distinguish those cells into motor nerve cells. The business needs to choose in between 3 significant instructions-- tools, drug advancement of therapies-- where it can guide business and continuously establish its innovation. iPierian needs to likewise make this choice in the context of the function of big medicine gamers in the market with who they can both partner or possibly contend versus in the race to discover effective applications for iPSC innovation.
This is just an excerpt. This case is about Business
Related Case Solutions & Analyses:
Buchanan Renewables: Bringing Power to Liberia
Ranger Creek Brewing and Distilling
GreenWood Resources: A Global Sustainable Venture in the Making
The Power of Asking Pivotal Questions
Syngenta: Committing to Africa
Which Strategy When?
Starlab: Transforming Ideas into Business
Designing for Growth: A Tool Kit for Managers
The Women’s Tennis Association Comes to China – But Who? (B)
Negotiation Exercise on Tradeable Pollution Allowances: Group A, Utility #1
